anti-PAR2 therapeutics (Sosei Heptares/PeptiDream)

N/A

Report date: 2025/03/14 16:22:40

Base Information

Drug Nameanti-PAR2 therapeutics (Sosei Heptares/PeptiDream)
Drug Alias Nameanti-PAR2 therapeutics (Heptares Therapeutics)anti-PAR2 therapeutics (Heptares/PeptiDream)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProtease-activated receptor-2 antagonists
TargetsProtease-activated receptor-2
Therapy Area/IndicationsInflammationInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma UK Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncNxera Pharma Co Ltd
Inactive CompaniesNxera Pharma UK Ltd
Active IndicationsInflammationInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A